Send us a text World Heart Federation host Shreya Shrikhande speaks with Mike Lane from the Amyloidosis Army and David Gregory from the Amyloidosis Alliance on their powerful journeys with ATTR-CM. They share the challenges of misdiagnosis, treatment access, community support, and the urgent need for awareness and early detection of transthyretin amyloid cardiomyopathy. Find out more about Transthyretin Amyloid Cardiomyopathy ATTR-CM on World Heart Federation website.
All content for World Heart Podcasts is the property of World Heart Federation and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text World Heart Federation host Shreya Shrikhande speaks with Mike Lane from the Amyloidosis Army and David Gregory from the Amyloidosis Alliance on their powerful journeys with ATTR-CM. They share the challenges of misdiagnosis, treatment access, community support, and the urgent need for awareness and early detection of transthyretin amyloid cardiomyopathy. Find out more about Transthyretin Amyloid Cardiomyopathy ATTR-CM on World Heart Federation website.
Conversations from the Heart with Prof Laurence Sperling
World Heart Podcasts
28 minutes
8 months ago
Conversations from the Heart with Prof Laurence Sperling
Send us a text Wrap up February with the latest episode of the World Heart Podcast! This time, hosts Lisa Hadeed and Shreya Shrikhande, PhD welcome Prof. Laurence (Larry) Sperling, a leading expert in preventive cardiology, to discuss the critical connection between influenza and heart health. Prof. Sperling shares key insights on how the flu can increase cardiovascular risks, why the annual flu shot is a powerful heart disease prevention strategy, and what steps we can take to protect oursel...
World Heart Podcasts
Send us a text World Heart Federation host Shreya Shrikhande speaks with Mike Lane from the Amyloidosis Army and David Gregory from the Amyloidosis Alliance on their powerful journeys with ATTR-CM. They share the challenges of misdiagnosis, treatment access, community support, and the urgent need for awareness and early detection of transthyretin amyloid cardiomyopathy. Find out more about Transthyretin Amyloid Cardiomyopathy ATTR-CM on World Heart Federation website.
